Documents

in page functions
1 - 10 of 11 matches Page: 1 2 

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

Searching... One moment please

01 November 2007

Evaluation of the first five years of GAVI Immunisation Services Support funding: follow-up on recommendations

Formal response by the GAVI Senior Management team for the GAVI Alliance Board to the recommendations of the 'Evaluation of the first five years of GAVI Immunisation Services Support funding'.

01 September 2007

Evaluation of the first five years of GAVI Immunisation Services Support funding

As GAVI enters its second phase, it is interested in evaluating whether ISS funding continues to further GAVI's objectives, and how best to maximise any positive impact. The Request for Proposal (RFP) issued by GAVI indicated three specific objectives: to assess the experience of the ISS scheme in Phase 1 (2000-2005); to assess the application [implementation] of ISS funding at country level and its relation to overall immunisation financing; to identify the relationship between the allocation of ISS funding and immunisation coverage rates (DTP3)

29 June 2007

Independent Expert Committee Recommendation for AMC Pilot

The Independent Expert Committee was convened to assess which of the six vaccines included in the Tremonti report would be most suitable for the pilot AMC.

11 March 2007

EEG Donor response

In May 2007, the AMC Donor Committee constituted an independent Economic Expert Group (EEG) to advise on the initial AMC design. This document is the donors' response to the EEG report.

09 February 2007

Bill and Melinda Gates Foundation - Statement of Support

Statement from the Bill and Melinda Gates foundation announcing support for the pneumococcal AMC.

09 February 2007

Pope Address at Vaccine Project Launch

The address Pope Benedict XVI gave to the representatives of the Advance Market Commitment in Rome, Italy on 9 February 2007.

09 February 2007

Remarks by Her Majesty Queen Rania of Jordan on the AMC Launch 2007

Remarks of Her Majesty Queen Rania Al-Abdullah on the announcement of Advanced Market Commitments of $1.5 billion in Rome, Italy on 9 February 2007.

09 February 2007

IFPMA Press Release in support of AMC Launch

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) welcomes the public commitment made by the governments of Canada, Italy, Norway and the United Kingdom to fund the pilot Advance Market Commitment (AMC) to stimulate the development of new pneumococcal vaccines for the poorest countries.

08 February 2007

Pneumococcal Disease Background

Streptococcus pneumoniae are bacteria that are frequently found in the upper respiratory tract of healthy children and adults. These bacteria, however, can also cause a range of infections – from relatively mild ear infections to fatal pneumonia, meningitis, and sepsis. Serious pneumococcal infections can occur throughout life, but children under two years old and the elderly are at highest risk. 

08 February 2007

Pneumococcal Disease - The Human Face

Stories of three young children in Africa and Asia and their fight against pneumococcal disease.

Searching... One moment please




close icon

modal window here